2. Gene
  3. C2 - complement C2 Gene

C2 - complement C2 Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品
  • 直系同源

中文名称：补体 C2

种属: Homo sapiens

同用名: CO2; ARMD14

基因 ID: 717 | 基因类型: protein coding

关于 C2

Cytogenetic location: 6p21.33 Genomic coordinates (GRCh38): 6:31,897,783-31,945,672 (from NCBI)

This gene has 24 transcripts (splice variants), 1 gene allele, 85 orthologues, 39 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 95.8), lung (RPKM 36.7) and 11 other tissues.

功能概要

组分 C2 是一种血清糖蛋白，作为补体系统经典途径的一部分发挥作用。激活的 C1 将 C2 切割成 C2a 和 C2b。然后丝氨酸蛋白酶 C2a 与补体因子 4b 结合产生 C3 或 C5 转化酶。据报道，C2 缺陷与某些自身免疫性疾病有关，并且该基因中的 SNP 与年龄相关性黄斑变性的易感性改变有关。该基因定位于 6 号染色体短臂上 MHC 的 III 类区域。可变剪接导致编码不同亚型的多个转录变体。已在出版物中描述了其他转录变体，但尚未确定其全长序列。[RefSeq 提供，2009 年 3 月]

Component C2 is a serum glycoprotein that functions as part of the classical pathway of the Complement System. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]

C2 基因产物(6)

mRNA Protein Name
NM_000063.6 NP_000054.2 complement C2 isoform 1 preproprotein
NM_001145903.3 NP_001139375.1 complement C2 isoform 2 precursor
NM_001178063.3 NP_001171534.1 complement C2 isoform 3
NM_001282457.2 NP_001269386.1 complement C2 isoform 4
NM_001282458.2 NP_001269387.1 complement C2 isoform 5
NM_001282459.2 NP_001269388.1 complement C2 isoform 6 precursor

C2 蛋白结构

Sushi

Sushi: Sushi repeat (SCR repeat) (89 - 144)

Sushi

Sushi: Sushi repeat (SCR repeat) (151 - 204)

VWA

VWA: von Willebrand factor type A domain (254 - 452)

Trypsin

Trypsin: Trypsin (473 - 703)

  • 0
  • 200
  • 400
  • 600
  • 752 a.a.
蛋白主名 其他名称

complement C2

C3/C5 convertase

重组 C2 蛋白

目录号 产品名 蛋白编号 纯度
HY-P74375 C2/Complement C2 Protein, Human (HEK293, His) P06681 (A21-L752) ≥95%
HY-P74376 C2/Complement C2 Protein, Human (HEK293, Fc) P06681 (A21-L752) ≥95%

关联疾病

疾病名称 别名
Complement Component 2 Deficiency

C2D

C2 Deficiency

Complement 2 Deficiency

Complement Component-2
Macular Degeneration, Age-Related, 14

Age Related Macular Degeneration 14

ARMD14

Macular Degeneration, Age-Related, 14, Reduced Risk Of

Macular Degeneration, Age-Related, Type 14
Immunodeficiency Due To A Classical Component Pathway Complement Deficiency

Immunodeficiency Due To C1, C4, Or C2 Component Complement Deficiency

Immunodeficiency Due To An Early Component Of Complement Deficiency
Retinal Drusen
Eye Disease

Eye Diseases

Abnormality Of The Eye

Toxoplasma Oculopathy
Lupus Erythematosus

Lupus

Lupus Vulgaris

Lupus Erythematosus, Discoid

Lupus Erythematosus, Systemic

Subacute Cutaneous Lupus

Le - [Lupus Erythematosus]
Macular Degeneration, Age-Related, 1

Macular Degeneration

Age-Related Macular Degeneration

Macular Degeneration, Age-Related

Age Related Macular Degeneration

Age Related Macular Degeneration 1

ARMD1

Senile Macular Degeneration

Maculopathy, Age-Related, 1

Macular Degeneration, Age-Related, Reduced Risk Of

Age Related Maculopathy 1

Age Related Maculopathies

Age Related Maculopathy

Senile Macular Retinal Degeneration

Macular Degeneration Of Retina

Age-Related Maculopathy

Amd

Armd

Age-Related Maculopathy, Susceptibility To

Maculopathy Age-Related

Macular Degeneration, Age-Related, 1, Susceptibility To

Maculopathy, Age-Related

Macular Degeneration, Age-Related, Type 1

Macular Degeneration, Age-Related, 2
Systemic Lupus Erythematosus

Lupus Nephritis

SLE

Disseminated Lupus Erythematosus

Systemic Lupus Erythematosus, Susceptibility To

Lupus Erythematosus, Systemic

Lupus Nephritis, Susceptibility To

Libman-Sacks Disease

Systemic Lupus Erythematosus Susceptibility To

Sle - Lupus Erythematosus, Systemic

Le Syndrome

Lupus

Lupus Erythematosus Systemic

Lupus Erythematosus, Systemic, Susceptibility To

Lupus Vulgaris

Lupus Erythematosus, Discoid

Lupus Erythematosus

Systemic Lupus Erythematosus Nos

Sle - [Systemic Lupus Erythematosus]
Degeneration Of Macula And Posterior Pole

Degeneration Of Macula And Posterior Pole Of Retina

Degeneration Of Macula Or Posterior Pole

Macular Degeneration Nos

Degenerative Disorder Of Macula

Drusen Macular Degeneration

Posterior Pole Macular Degeneration Of Eye

Macular Eye Degeneration

Macular Degeneration Of Retina, Unspecified

Pseudohole Degeneration Of Macula Of Retina
Hemolytic Uremic Syndrome, Atypical 1

Atypical Hemolytic-Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1

Atypical Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To

Ahus

AHUS1

Hemolytic-Uremic Syndrome

Ahus 1

Ahus, Susceptibility To, 1

Hemolytic Uremic Syndrome, Atypical

Non-Shiga-Like Toxin-Associated Hus

Non-Stx-Hus

Nonenteropathic Hus

Atypical Hus

Shiga Toxin-Associated Hemolytic Uremic Syndrome

D+ Hus

Ehec-Hus

Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli

Hemolytic Uremic Syndrome With Diarrhea

Stec-Hus

Shiga-Like Toxin-Associated Hus

Stx-Hus

Typical Hus

Typical Hemolytic Uremic Syndrome

Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies

Atypical Hus With Anti-Factor H Antibodies

Ahus With Anti-Factor H Antibodies

Ahus With Neutralizing Autoantibodies Against Factor H

Hemolytic Uremic Syndrome Atypical 1

Atypical Hemolytic Uremic Syndrome With H Factor Anomaly

D Hus

Hemolytic-Uremic Syndrome Without Diarrhea

Hemolytic-Uremic Syndrome, Atypical, Type 1

Hemolytic Uremic Syndrome, Typical
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-14544 Quetiapine 99.88% 是
HY-B0031 Quetiapine hemifumarate 99.94% 是
HY-B1915 Micronomicin Inhibitor 95.16% 否
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P99050 Sutimlimab Inhibitor 98.81% 否
Clinical Phase
生物活性分子 (2)
目录号 产品名 作用方式
纯度 Phase
HY-N0379 D-Mannose ≥98.0% Phase 4
HY-113697 Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 99.77% Phase 1
抗体抑制剂 (3)
目录号 产品名 作用方式
纯度 Phase
HY-P990091 Riliprubart Inhibitor 99.90% Phase 3
HY-P99163 Tilavonemab Inhibitor 96.22% Phase 2
HY-P990025 Empasiprubart 97.93% Phase 2
Pre-clinical Phase
生物活性分子 (716)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-N0155 Nobiletin 99.52% 否
HY-113071A Mevalonic acid lithium salt 99.80% 否
HY-40171 NH2-C2-NH-Boc 99.97% 否
HY-W021401 Amino-PEG3-C2-Azido 99.67% 否
HY-N0376 Liquiritin 99.68% 否
HY-140213 Azido-PEG2-C2-amine 99.85% 否
HY-130109 N3-PEG4-C2-NHS ester 98.94% 否
HY-117974 Durlobactam sodium Inhibitor 99.38% 否
HY-101180 C2 Ceramide 99.85% 否
HY-42776 NH2-PEG3-C2-NH-Boc 99.34% 否
HY-W008474 Boc-NH-PEG2-C2-NH2 99.01% 否
HY-122502 Pyrazofurin Inhibitor ≥98.0% 否
HY-128834 N3-PEG4-C2-NH2 ≥98.0% 否
HY-100594 EUK-134 Inhibitor 98.08% 否
HY-126528 N3-PEG3-C2-NHS ester 99.94% 否
HY-130653 Azido-PEG4-C2-acid ≥98.0% 否
HY-150795 SY-LB-35 ≥98.0% 否
HY-126526 N3-PEG2-C2-NHS ester ≥98.0% 否
HY-W015088 Amino-PEG3-C2-Amine 99.32% 否
HY-W015913S Sodium 2-oxopropanoate-13C3 Inhibitor 99.7% 否
HY-137320 diABZI-C2-NH2 Agonist 96.09% 否
HY-130485 Bromo-PEG2-C2-azide 98.10% 否
HY-140452 Azido-PEG2-C2-acid ≥97.0% 否
HY-42149 NH2-PEG2-C2-Boc ≥98.0% 否
HY-N0602 Ginsenoside Rg2 Inhibitor 98.11% 否
HY-135804 NH2-PEG3-C2-Boc ≥97.0% 否
HY-112821 IBS008738 Activator 98.22% 否
HY-130549 Acid-PEG3-C2-Boc ≥97.0% 否
HY-W092043 TLR4-IN-C34-C2-COOH Inhibitor ≥97.0% 否
HY-107452 SLF-amido-C2-COOH 99.82% 否
HY-125843 Pomalidomide-PEG1-C2-N3 99.91% 否
HY-W022240 NH2-PEG5-C2-NH-Boc ≥95.0% 否
HY-W011235 Norfluoxetine hydrochloride Inhibitor 99.58% 否
HY-147007 β-catenin-IN-3 Inhibitor 98.03% 否
HY-150644 S07-2010 Inhibitor 99.79% 否
HY-156406 PITCOIN4 Inhibitor 99.97% 否
HY-42151 Mal-amido-PEG2-C2-acid 99.58% 否
HY-140009 Azido-PEG1-C2-acid ≥98.0% 否
HY-D0187S L-Glutathione reduced-13C2,15N Inhibitor ≥99.0% 否
HY-126502 Mal-C2-NHS ester 99.30% 否
HY-130436 Acid-C2-PEG4-C2-NHS ester ≥98.0% 否
HY-W017970 Boc-C2-NH2 99.63% 否
HY-124569 NAB-14 Antagonist 98.26% 否
HY-126520 N3-C2-NHS ester ≥98.0% 否
HY-140480 Acid-PEG2-C2-Boc ≥98.0% 否
HY-112820 Chlorantraniliprole Activator 98.06% 否
HY-141364 Bromo-PEG1-C2-Boc 98.58% 否
HY-148896 (S,R,S)-AHPC-C2-PEG3-BCN ≥98.0% 否
HY-163084 HJ445A Inhibitor 98.31% 否
HY-W040165 Amino-PEG3-C2-acid 99.94% 否
HY-101159 Mal-amido-PEG8-C2-acid 99.04% 否
HY-108307 Micronomicin sulfate Inhibitor ≥98.0% 否
HY-112452 SU11652 99.06% 否
HY-128846A Pomalidomide-C2-NH2 hydrochloride 99.46% 否
HY-148346A STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA Agonist 98.20% 否
HY-22335 Amino-PEG4-C2-amine ≥98.0% 否
HY-W040168 Amino-PEG2-C2-acid ≥98.0% 否
HY-119678 Fortunellin Activator 96.51% 否
HY-124648 SMN-C2 98.85% 否
HY-130315 Br-PEG4-C2-Boc ≥98.0% 否
HY-130483 Br-PEG3-C2-Boc ≥97.0% 否
HY-140127 Azide-C2-SS-C2-biotin 98.79% 否
HY-147025 (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine 99.06% 否
HY-B0351S2 Taurine-13C2,15N Inducer 98.60% 否
HY-W021448S1 Glycocyamine-15N,13C2 ≥97.0% 否
HY-129703B Thalidomide-PEG2-C2-NH2 hydrochloride Inducer 99.89% 否
HY-112599B Pomalidomide-PEG4-C2-NH2 hydrochloride 97.01% 否
HY-112706 PF-06747711 Antagonist 99.86% 否
HY-131880 Thalidomide-O-C2-acid Inducer 95.04% 否
HY-137531 Pomalidomide-PEG1-C2-COOH 99.76% 否
HY-N0322S5 Cholesterol-13C2 Agonist 99.76% 否
HY-N0543S Allantoin-13C2,15N4 99.90% 否
HY-N1517 Ganoderic acid C2 99.30% 否
HY-W010098S1 Terephthalic acid-13C2 98.58% 否
HY-W580022 Pomalidomide-5'-PEG8-C2-COOH 98.21% 否
HY-128716A Pomalidomide-PEG3-C2-NH2 TFA 99.0% 否
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.04% 否
HY-128832 Nutlin-C1-amido-PEG4-C2-N3 99.19% 否
HY-115384 Amino-PEG5-C2-acid ≥97.0% 否
HY-135868 Mito-apocynin (C2) Inhibitor 98.38% 否
HY-139848 WS-898 Inhibitor 98.14% 否
HY-140543 N-DBCO-N-bis(PEG2-C2-acid) 96.65% 否
HY-141386 Bromoacetamido-PEG2-C2-NHS ester ≥95.0% 否
HY-B0228S10 (R)-3-Hydroxybutanoic acid-13C2 sodium ≥98.0% 否
HY-N7627 Regaloside C ≥99.0% 否
HY-P5881 PKCα (C2-4) inhibitor peptide Inhibitor 99.81% 否
HY-W039168 Bromo-PEG3-C2-acid ≥97.0% 否
HY-Y0262S1 Oxalic acid-13C2 99.45% 否
HY-Y0966S6 Glycine-13C2,15N ≥99.0% 否
HY-N0091S3 Hypoxanthine-13C2,15N ≥91.0% 否
HY-13836 ELQ-300 Inhibitor ≥98.0% 否
HY-122710A Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Inducer ≥95.0% 否
HY-136163 (S,R,S)-AHPC-C2-NH2 dihydrochloride 98.63% 否
HY-130108 N3-PEG4-C2-Pfp ester ≥97.0% 否
HY-130414 Mal-amido-PEG4-acid 99.39% 否
HY-133597 4-Chlorocatechol 99.37% 否
HY-134512 Aminooxy-PEG3-C2-thiol ≥95.0% 否
HY-140585 N-DBCO-N-bis(PEG2-C2-NHS ester) ≥96.0% 否
HY-140819 Bromo-PEG1-C2-azide 99.45% 否
HY-141240 Hydroxy-PEG2-C2-methyl ester 98.48% 否
HY-141365 Bromo-PEG2-C2-Boc ≥97.0% 否
HY-23167 Acid-PEG4-C2-Boc / 否
HY-Y0966S3 Glycine-13C2 99.10% 否
HY-129703A Thalidomide-PEG2-C2-NH2 TFA Inducer 99.39% 否
HY-107440A Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Inducer 98.29% 否
HY-112608 CHMFL-PI3KD-317 Inhibitor 98.04% 否
HY-122694A Thalidomide-O-amido-PEG-C2-NH2 hydrochloride Inducer 98.10% 否
HY-130521 Pomalidomide-amido-PEG3-C2-NH2 99.55% 否
HY-100246 CI-1044 Inhibitor 98.02% 否
HY-115450 ONO-0300302 Antagonist 99.43% 否
HY-126512 Propargyl-C2-NHS ester ≥95.0% 否
HY-126688 Mal-C2-Gly3-EDA-PNU-159682 93.43% 否
HY-126881 Fmoc-PEG2-C2-NHS ester 98.89% 否
HY-130095 NHPI-PEG2-C2-NHS ester 98.23% 否
HY-130101 Ald-Ph-amido-PEG4-C2-NHS ester 98.75% 否
HY-130396 DBCO-PEG4-C2-acid 99.22% 否
HY-130520 Bromoacetamido-PEG4-C2-Boc ≥97.0% 否
HY-130531 NH-bis(C2-PEG2-NH-Boc) ≥98.0% 否
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.76% 否
HY-134682 Fmoc-NH-PEG5-C2-NH2 98.06% 否
HY-136162 Thalidomide-4-O-C2-NH2 hydrochloride Inducer 99.37% 否
HY-13966S2 2-Deoxy-D-glucose-13C ≥98.0% 否
HY-141362 Bromo-PEG2-C2-acid ≥97.0% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% 否
HY-148080 Indole-C2-amide-C2-NH2 99.42% 否
HY-162809 XMU-MP-9 98.16% 否
HY-B0031R Quetiapine hemifumarate (Standard) 99.87% 否
HY-B0351S1 Taurine-13C2 Inducer 99.0% 否
HY-B0389S15 D-Glucose-13C2-4 ≥98.0% 否
HY-N6980 Licorice glycoside C2 99.07% 否
HY-W017387S1 Alpha-ketoisocaproic acid-13C2 sodium 98.1% 否
HY-133358 Cbz-NH-PEG12-C2-acid 95.66% 否
HY-W025074 BML-278 Activator 98.49% 否
HY-W128417S 4-(Dimethylamino)phenacyl bromide-13C2,d6 98.14% 否
HY-107440 Thalidomide-O-amido-PEG3-C2-NH2 Inducer / 否
HY-112600A Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA Inducer 99.28% 否
HY-112617A Thalidomide-O-amido-PEG2-C2-NH2 TFA Inducer 99.72% 否
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / 否
HY-130853 Thalidomide-NH-PEG2-C2-NH-Boc Inducer 98.37% 否
HY-112599 Pomalidomide-PEG4-C2-NH2 95.11% 否
HY-128591 DIPQUO Activator 98.70% 否
HY-103154 SB228357 Antagonist 99.43% 否
HY-103611 Thalidomide-O-amido-PEG3-C2-NH2 TFA Inducer 99.55% 否
HY-108440 Shz-1 99.88% 否
HY-113071 Mevalonic acid ≥99.0% 否
HY-120773 Fmoc-PEG3-C2-NHS ester ≥95.0% 否
HY-121982 Cyclo(L-Phe-L-Val) Inhibitor 99.88% 否
HY-126381 Boc-N-PEG5-C2-NHS ester 96.91% 否
HY-126507 Mal-amido-PEG1-C2-​NHS ester 99.69% 否
HY-126509 Mal-amido-PEG10-C2-​NHS ester 95.23% 否
HY-128716 Pomalidomide-PEG3-C2-NH2 / 否
HY-128716B Pomalidomide-PEG3-C2-NH2 hydrochloride / 否
HY-128846 Pomalidomide-C2-NH2 / 否
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% 否
HY-130097 Ald-Ph-amido-PEG4-C2-acid 99.09% 否
HY-130104 Ald-Ph-amido-PEG2-C2-NHS ester 98.51% 否
HY-130470 Chloroacetamido-PEG4-C2-Boc / 否
HY-131866 (S,R,S)-CO-C2-acid ≥98.0% 否
HY-133070 Tos-PEG5-C2-Boc / 否
HY-135085 Thiol-C2-PEG2-OH ≥97.0% 否
HY-136395 Cartap Inducer / 否
HY-13677S1 6-Mercaptopurine-13C2,15N ≥96.0% 否
HY-138446 Amino-PEG4-C2-SH hydrochloride ≥95.0% 否
HY-138451 Amino-PEG7-C2-SH hydrochloride ≥98.0% 否
HY-140779 Azido-PEG6-C2-Boc 99.77% 否
HY-141380 Bromoacetamido-PEG2-C2-acid 99.11% 否
HY-141941S Triazole Lactic Acid-13C2, 15N3 / 否
HY-148136 sEH inhibitor-7 Inhibitor 99.71% 否
HY-148346 STING agonist-20-Ala-amide-PEG2-C2-NH2 Agonist / 否
HY-148484 Pomalidomide-5'-PEG5-C2-COOH 98.80% 否
HY-160897 Methoxy-PEG-C3-amide-C2-Mal 99.69% 否
HY-164367 Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT / 否
HY-16973S Fluralaner-13C2,15N,d3 Inhibitor 98.35% 否
HY-17563S2 2'-Deoxyguanosine-13C10 99.8% 否
HY-66005S4 Acetaminophen-13C2,15N / 否
HY-A0132S10 N-Acetyl-D-glucosamine-13C2,15N / 否
HY-B0166S3 L-Ascorbic acid-13C-2 ≥95.0% 否
HY-B0318S Metronidazole-13C2,15N2 99.30% 否
HY-I0960S Uracil-13C2,15N2 ≥97.0% 否
HY-N0229S15 L-Alanine-13C2,15N ≥99.0% 否
HY-N0229S9 L-Alanine-13C2 ≥98.0% 否
HY-N0437S3 Progesterone-13C2 Agonist 99.7% 否
HY-N0455AS5 L-Arginine-1,2-13C2 hydrochloride Activator 98.9% 否
HY-N0666S6 L-Aspartic acid-1,4-13C2 ≥99.0% 否
HY-N0830S10 Palmitic acid-13C2 Activator 99.54% 否
HY-P2741 Maltose phosphorylase / 否
HY-W013636S3 2-Ketoglutaric acid-13C ≥97.0% 否
HY-W040329S1 2'-Deoxyadenosine-13C10 ≥99.0% 否
HY-W040795 N2-Acetylguanine 99.69% 否
HY-W127841 Citric acid-2,4-13C2 98.00% 否
HY-Y0674S Dicyandiamide-13C2,15N2 99.90% 否
HY-Y0966S2 Glycine-2-13C 99.30% 否
HY-103708 Nezukone 98.81% 否
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% 否
HY-47373 Folate-PEG3-C2-acid 97.56% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 ≥98.0% 否
HY-112600 Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Inducer / 否
HY-112617 Thalidomide-O-amido-PEG2-C2-NH2 Inducer / 否
HY-112617B Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-122694 Thalidomide-O-amido-PEG-C2-NH2 Inducer / 否
HY-128353 ROR agonist-1 Antagonist / 否
HY-129703 Thalidomide-PEG2-C2-NH2 Inducer / 否
HY-131308 Thalidomide-NH-C2-PEG3-OH Inducer / 否
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride Inducer / 否
HY-141662 2',3'-cGAMP-C2-PPA Agonist / 否
HY-122710 Thalidomide-O-amido-PEG4-C2-NH2 / 否
HY-125883 Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc / 否
HY-100441S1 Treprostinil-13C2,d1 Inhibitor / 否
HY-100582S1 Ribitol-2-13C / 否
HY-101047S1 D-erythro-Sphingosine-13C2,d2 / 否
HY-101108S1 Tazarotenic acid-13C2,d2 / 否
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / 否
HY-103155 SB-221284 Antagonist / 否
HY-106950CS1 Fosfructose-2-13C sodium / 否
HY-107698 PMPA (NMDA antagonist) Antagonist / 否
HY-108379 Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid / 否
HY-108826 Iduronate sulfatase / 否
HY-109506S9 DPPC-13C2 / 否
HY-110189S Pregnenolone monosulfate sodium-13C2,d2 / 否
HY-111095S3A D-(-)-Lactic acid-13C-2 sodium / 否
HY-113071C (S)-Mevalonic acid / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113263S1 17α-Hydroxypregnenolone-13C2,d2 / 否
HY-113295S Salicyluric acid-13C2,15N / 否
HY-113365S2 Cholestenone-13C2 / 否
HY-115945 Complex III-IN-1 Inhibitor / 否
HY-116463A (2R,3S)-E1R Agonist 98.84% 否
HY-116877 C2 Ceramide (d14:1/2:0) / 否
HY-117356A MRS2693 ammonium / 否
HY-117792 LY314228 Antagonist / 否
HY-118574 UBP141 Antagonist / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-120678 DBCO-PEG4-acid / 否
HY-121507 Hydroxy-PEG2-C2-sulfonic acid / 否
HY-123439 FTY720-C2 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125172 PolyQ aggregation inhibitor C2-8 / 否
HY-125887 Boc-NH-PEG2-C2-amido-C4-acid / 否
HY-126026 NF-κB-IN-17 Inhibitor / 否
HY-126313 BnOH-NH-bis-(C2-S)-propane-O-isoprene ester / 否
HY-126508 Mal-amido-PEG5-C2-​NHS ester / 否
HY-12650S Mirogabalin-13C2,d1 (Mixture of Diastereomers) / 否
HY-126510 MC-PEG2-C2-​NHS ester / 否
HY-126514 Propargyl-O-C1-amido-PEG2-C2-NHS ester / 否
HY-126515 Propargyl-O-C1-amido-PEG4-C2-NHS ester / 否
HY-126527 N3-PEG2-C2-PFP ester / 否
HY-126529 N3-PEG3-C2-PFP ester / 否
HY-126673 Mal-C2-Gly3-EDA / 否
HY-126677 Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA / 否
HY-126949 Aminooxy-PEG3-azide / 否
HY-128741S2 D-Allose-13C-2 / 否
HY-128753S3 D-Lyxose-13C-2 / 否
HY-128793S trans-Stilbene-13C2 / 否
HY-129772 Phthalimide-PEG3-C2-OTs / 否
HY-130090 NHPI-PEG4-C2-Pfp ester / 否
HY-130091 NHPI-PEG4-C2-NHS ester 98.88% 否
HY-130092 NHPI-PEG3-C2-Pfp ester / 否
HY-130093 NHPI-PEG3-C2-NHS ester / 否
HY-130094 NHPI-PEG2-C2-Pfp ester / 否
HY-130096 Ald-Ph-amido-C2-nitrate / 否
HY-130102 Ald-Ph-amido-PEG3-C2-Pfp ester / 否
HY-130103 Ald-Ph-amido-PEG2-C2-Pfp ester / 否
HY-130105 Ald-Ph-amido-PEG1-C2-Pfp ester / 否
HY-130106 Ald-Ph-amido-PEG1-C2-NHS ester / 否
HY-130154 Ald-Ph-amido-PEG2-C2-acid / 否
HY-130164 Bromo-PEG3-C2-phosphonic acid / 否
HY-130174 Ald-Ph-amido-PEG3-C2-NH2 / 否
HY-130192 Cbz-NH-PEG8-C2-acid / 否
HY-130202 Ald-Ph-amido-PEG2-C2-Boc ≥97.0% 否
HY-130443 Cbz-NH-PEG6-C2-acid / 否
HY-130467 DNP-NH-PEG2-C2-acid / 否
HY-130488 Hydroxy-PEG2-C2-PFP ester / 否
HY-130489 Bromo-PEG5-C2-acid / 否
HY-130491 DNP-NH-PEG4-C2-Boc / 否
HY-130599 Hydroxy-PEG2-CH2-Boc / 否
HY-130654 (S,R,S)-AHPC-C2-PEG4-N3 / 否
HY-130667 Ald-Ph-amido-C2-PEG3-azide 98.92% 否
HY-130669 Ald-Ph-amido-C2-PEG3-NH-Boc / 否
HY-130690 Propargyl-PEG1-SS-PEG1-C2-Boc ≥98.0% 否
HY-130712 NH2-C2-amido-C2-Boc / 否
HY-130713 Thalidomide-C2-amido-C2-COOH Inducer / 否
HY-130758 Ald-PEG1-C2-Boc / 否
HY-130931 Propargyl-NH-PEG3-C2-NHS ester / 否
HY-131992 N-Acetylpsychosine / 否
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc ≥95.0% 否
HY-133069 Tos-PEG2-C2-Boc / 否
HY-133071 Tos-PEG6-C2-Boc / 否
HY-133410 Mal-C2-cyclohexylcarboxyl-hydrazide TFA / 否
HY-133410A Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride 98.23% 否
HY-133509 DBCO-C2-SulfoNHS ester / 否
HY-133546 Ald-Ph-amido-PEG11-C2-NH2 / 否
HY-133583 Propargyl-O-C1-amido-PEG3-C2-NHS ester / 否
HY-133694S 2-Aminoflubendazole-13C6 / 否
HY-13407S Gossypol-13C2 / 否
HY-13417S AICAR-13C2,15N / 否
HY-13458S1 Droxidopa-13C2,15N hydrochloride / 否
HY-135931 m-PEG11-C2-NHS Ester / 否
HY-135959 DBCO-NH-PEG7-C2-NHS ester / 否
HY-136162A Thalidomide-4-O-C2-NH2 Inducer / 否
HY-136163A (S,R,S)-AHPC-C2-NH2 / 否
HY-13623CS (1R,3S,4R)-ent-Entecavir-13C2,15N / 否
HY-13623S1 Entecavir-13C2,15N / 否
HY-136457S 2-NP-AHD-13C3 / 否
HY-136648S5 2'-Deoxyadenosine-5'-triphosphate-13C10 dilithium / 否
HY-138083 Parvodicin C2 Inhibitor / 否
HY-138098 Sartorypyrone B / 否
HY-138316 THP-PEG10-C2-Boc / 否
HY-138349 THP-PEG6-C2-Boc / 否
HY-138358 Azido-PEG23-C2-azide / 否
HY-138362 Br-PEG6-C2-acid / 否
HY-138370 Boc-NH-PEG4-C2-Boc / 否
HY-138375 Mal-PEG5-C2-NH2 hydrochloride / 否
HY-138380 Mal-PEG4-C2-NH2 TFA / 否
HY-138381 Br-PEG6-C2-NHBoc / 否
HY-138384 Br-PEG9-C2-NHBoc / 否
HY-138390 NH2-PEG10-C2-dimethylamino / 否
HY-138397 Boc-NH-PEG15-C2-acid / 否
HY-138399 Boc-NH-PEG22-C2-NH2 / 否
HY-138406 Boc-NH-PEG8-C2-Br / 否
HY-138410 Boc-NH-PEG11-C2-acid / 否
HY-138425 Amino-PEG12-C2-azide / 否
HY-138432 Boc-NH-PEG26-C2-NH2 / 否
HY-138464 Br-Boc-C2-azido / 否
HY-138474 Boc-PEG1-PPG2-C2-azido / 否
HY-138485 Boc-PEG1-PPG2-C2-NH2 / 否
HY-138535 Azide-C2-Azide / 否
HY-138616S3 dGTP-13C10 dilithium / 否
HY-138849 Thalidomide-NH-amido-C2-NH2 Inducer / 否
HY-138849A Thalidomide-NH-amido-C2-NH2 hydrochloride Inducer / 否
HY-138854 Thalidomide-NH-amido-PEG1-C2-NH2 Inducer / 否
HY-138854A Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride Inducer / 否
HY-138855 Thalidomide-NH-amido-PEG2-C2-NH2 Inducer / 否
HY-138855A Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-138856 Thalidomide-NH-amido-PEG3-C2-NH2 Inducer / 否
HY-138856A Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride / 否
HY-138857 Thalidomide-NH-amido-PEG4-C2-NH2 / 否
HY-138857A Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride / 否
HY-138965A Pomalidomide-5-C2-NH2 hydrochloride / 否
HY-139084 XL388-C2-NH2 / 否
HY-139085A XL388-C2-amide-PEG9-NH2 hydrochloride ≥95.0% 否
HY-139085B XL388-C2-amide-PEG9-NH2 TFA 95.97% 否
HY-13966S4 2-Deoxy-D-glucose-13C-1 / 否
HY-140001 Amino-PEG3-C2-sulfonic acid / 否
HY-140011 Acid-C2-PEG3-NHS ester / 否
HY-140067 endo-BCN-PEG2-C2-NHS ester / 否
HY-140085 N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) / 否
HY-140101 Azido-C2-SS-PEG2-C2-acid / 否
HY-140164 Azido-PEG2-C2-sulfonic acid / 否
HY-140221 Azido-PEG1-C2-methylamine / 否
HY-140287 DBCO-C2-PEG4-amine / 否
HY-140294 DBCO-C2-PEG4-NH-Boc / 否
HY-140349 AZD-CO-C2-Ph-amido-Ph-azide / 否
HY-140406 Aminooxy-PEG3-C2-NH-Boc / 否
HY-140487 Cbz-NH-PEG2-C2-acid / 否
HY-140489 Cbz-NH-PEG5-C2-acid / 否
HY-140514 NH-bis(PEG2-C2-acid) / 否
HY-140550 NH-bis(C2-PEG1-azide) / 否
HY-140554 N-Boc-N-bis(C2-PEG1-azide) / 否
HY-140595 m-PEG3-S-PEG1-C2-Boc / 否
HY-140633 Ald-C2-PEG4-azide / 否
HY-140750 Benzyloxy carbonyl-PEG3-C2-Boc / 否
HY-140776 Azido-PEG2-C2-Boc / 否
HY-140834 Boc-N-Amido-PEG2-C2-azide / 否
HY-141116 Boc-N-PEG1-C2-NHS ester / 否
HY-141122 Boc-PEG4-C2-NHS ester / 否
HY-141199 Bromoacetamido-C2-PEG2-NH-Boc / 否
HY-141212 Hydroxy-PEG3-PFP ester / 否
HY-141239 Hydroxy-PEG1-C2-methyl ester / 否
HY-141241 Hydroxy-PEG3-C2-methyl ester / 否
HY-141242 Hydroxy-PEG4-C2-methyl ester / 否
HY-141243 Hydroxy-PEG5-C2-methyl ester 98.97% 否
HY-141245 Hydroxy-PEG4-C2-nitrile / 否
HY-141323 C2-Bis-phosphoramidic acid diethyl ester / 否
HY-141349 S-Acetyl-PEG3-C2-acid / 否
HY-141381 Bromoacetamido-PEG3-C2-acid / 否
HY-141388 Bromoacetamido-PEG3-C2-Boc / 否
HY-141663 2',3'-cGAMP-C2-SH / 否
HY-141798 OICR-9429-N-C2-NH2 / 否
HY-141878 di-Ellipticine-RIBOTAC Modulator / 否
HY-143784S C14 Benzalkonium-1 acid-13C2,d11 chloride / 否
HY-143943S Felodipine 3,5-dimethyl ester-13C2,d6 / 否
HY-144128 hGGPPS-IN-1 / 否
HY-144129 hGGPPS-IN-2 / 否
HY-144130 hGGPPS-IN-3 / 否
HY-144150S Pelubiprofen impurity 2-13C2,d6 / 否
HY-144153S S-(1,2-Dichlorovinyl)glutathione-13C2,15N / 否
HY-144427S Vitamin E-13C2,d6 / 否
HY-145247 Biotin-PEG7-C2-S-Vidarabine Inhibitor / 否
HY-145248 Biotin-PEG7-C2-NH-Vidarabine-S-CH3 Inhibitor / 否
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-14608S10 L-Glutamic acid-13C2 / 否
HY-146194 NHEJ inhibitor-1 Activator / 否
HY-146196 Anticandidal agent-1 Inhibitor / 否
HY-146573 AKR1C3-IN-6 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146994S2 L-Idose-13C-2 / 否
HY-146995S1 Glycolaldehyde-2-13C / 否
HY-147716 CDK8-IN-6 Inhibitor / 否
HY-147717 CDK8-IN-7 Inhibitor / 否
HY-147835 Antibacterial agent 109 Inhibitor / 否
HY-148171 L-2'-Fd4C Inhibitor / 否
HY-148472A C2-Amide-C4-NH2 / 否
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / 否
HY-149255 PTP1B/AKR1B1-IN-2 Inhibitor / 否
HY-150525S Acetyl-1,2 Coenzyme A-13c2 Lithium / 否
HY-150623 SARS-CoV-2 nsp13-IN-2 Inhibitor / 否
HY-150631S Glutathione-glycine-13C2,15N trifluoroacetate / 否
HY-150915S Uracil 4,5-13c2 / 否
HY-150980S 1,2-O-Isopropylidene-β-L-idofuranuronic-6-13C acid γ-lactone / 否
HY-150981S 1,2-O-Isopropylidene-a-D-glucofuranuronic-6-13C acid, γ-lactone / 否
HY-152297 (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol / 否
HY-152305 (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol / 否
HY-152463 4′-C-2-Propen-1-yluridine / 否
HY-153042 Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride / 否
HY-153371 50-C2-C9-4tail / 否
HY-153538 AP-C2 Inhibitor / 否
HY-15388S1 Tazarotene-13C2,d2 / 否
HY-155705 BMP agonist 1 / 否
HY-156304 Coumarin-C2-TCO / 否
HY-156305 Coumarin-C2-exo-BCN / 否
HY-156882 Biotin-PEG3-amide-C2-CO-Halofuginone / 否
HY-157386S 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 / 否
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / 否
HY-157749 Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / 否
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / 否
HY-160449 p53 Activator 10 Activator / 否
HY-160514 LXQ46 Inhibitor / 否
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / 否
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / 否
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / 否
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / 否
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / 否
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / 否
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / 否
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / 否
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / 否
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / 否
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / 否
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / 否
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 / 否
HY-161393 RB-CO-PEG5-C2-CO-VH032 / 否
HY-161394 SPRT / 否
HY-161767 JWJ-01-306 / 否
HY-161839 AKR1C2/3-IN-1 Inhibitor / 否
HY-161910 SH-E4A-66 Inhibitor / 否
HY-162046 Anticancer agent 178 Inducer / 否
HY-162081 BTK-IN-32 Inhibitor / 否
HY-16271S Kevetrin hydrochloride-13C2,15N3 p53 Activator / 否
HY-163078 C2-Gal-Dox / 否
HY-163224 (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163228 PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163276 OX2R-IN-2 Agonist / 否
HY-163788 C5-CONH-C2-N-CH3 / 否
HY-163903 OH-C2-PEG3-NHCO-C3-COOH / 否
HY-163904 (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH / 否
HY-163930 (S,R,S)-AHPC-CO-cyclohexane-C2 / 否
HY-163986 Pomalidomide-C2-NHCO-C6 / 否
HY-164210 DBCO-PEG2-C2-acid / 否
HY-164212 DBCO-PEG1-OH / 否
HY-164785 TCO-PEG5-C2-Mal ≥95.0% 否
HY-168016 PROTAC YAP degrader-1 / 否
HY-168019 (R,S,R)-AHPC-PEG2-C2-boc / 否
HY-169082 JQ-1 (carboxylic acid)-NH-C2-NH-COOH / 否
HY-169141 BIIB021-NH-C2-piperidine-CO-Me / 否
HY-169150 JQ-1 carboxylic acid-PEG3-C2-NH2 / 否
HY-169236 COOH-C-PEG2-NHCO-C2-COOH / 否
HY-169237 Pomalidomide-C2-CONH-PEG2-C-COOH / 否
HY-17416AS1 Guanfacine-15N3,13C2 Agonist / 否
HY-17530S Aldicarb sulfone-13C2,d3 / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / 否
HY-40171S NH2-C2-NH-Boc-d4 / 否
HY-48394A Bis-S-C2-N(N-Me)-C2-OH dihydrochloride / 否
HY-77956S2 Thyminose-13C-2 / 否
HY-79369S1 Succinic anhydride-13C2 / 否
HY-90009AS Tadalafil-13C2,d3 / 否
HY-A0084S1 Procainamide-13C2 hydrochloride / 否
HY-B0031S2 Quetiapine-d8 fumarate / 否
HY-B0031S3 Quetiapine-d8 hemifumarate / 否
HY-B0031S4 Quetiapine hemifumarate-d8 / 否
HY-B0101S1 Fluconazole-13C2,15N Inhibitor / 否
HY-B0141S5 Estradiol-13C2 Agonist / 否
HY-B0149S3 Tranexamic acid-13C2,15N / 否
HY-B0151S1 Pregnenolone-13C2,d2 / 否
HY-B0216S2 Ethynyl Estradiol-13C2 Agonist / 否
HY-B0220S3 Erythromycin-13C2 Inhibitor / 否
HY-B0228S2 Adenosine-2′-13C / 否
HY-B0234S3 Estrone-13C2 Agonist / 否
HY-B0283S1 Acipimox-13C2,15N2 / 否
HY-B0389S12 D-Glucose-13C-2 / 否
HY-B0389S14 D-Glucose-13C2 / 否
HY-B0389S22 D-Glucose-13C2,d2 / 否
HY-B0400S3 D-Sorbitol-13C-2 / 否
HY-B0495S3 Lamotrigine-13C2,15N / 否
HY-B0495S6 Lamotrigine-13C2,15N2,d3 / 否
HY-B0508S1 Ornidazole-13C2,15N2 Inhibitor / 否
HY-B0523S Anagrelide-13C2,15N,d2 / 否
HY-B0579S3 Cyclosporin A-13C2,d4 Inhibitor / 否
HY-B0712S1 Ceftriaxone-13C2,d3 triethylammonium salt Inhibitor / 否
HY-B0782S1 Acetazolamide-13C2,d3 / 否
HY-B0863S3 Glyphosate-13C2,15N Inducer / 否
HY-B1118S1 Secnidazole-13C2, 15N2 Inhibitor / 否
HY-B1337S5 Choline-13C2 chloride / 否
HY-B1449S3 Uridine-13C-2 / 否
HY-B1640S Ethacrynic acid-13C2,d5 / 否
HY-B1659S4 Glycerol-13C2 / 否
HY-B1842S Fluroxypyr-13C2 / 否
HY-B1912S1 Amidosulfuron-13C2,d6 / 否
HY-D0184S5 2'-Deoxycytidine-13C9 / 否
HY-D1546 Biotin-C2-maleimide / 否
HY-D1551 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / 否
HY-I0400S2 N-Acetylneuraminic acid-13C-2 / 否
HY-I0626S Cytosine-2,4-13C2-1,3-15N2 / 否
HY-I0736S Isonicotinic acid-d4 / 否
HY-N0059S2 D-arabinose-13C-2 / 否
HY-N0090S Guanosine-1'-13C Monohydrate / 否
HY-N0210S1 D-Galactose-13C-2 / 否
HY-N0379S7 D-Mannose-13C-2 / 否
HY-N0390S10 L-Glutamine-1,2-13C2 / 否
HY-N0394S4 L-Cystine-3,3'-13C2 / 否
HY-N0420S3 Butanedioic acid-13C2 ≥99.0% 否
HY-N0420S4 Succinic acid-13C2 / 否
HY-N0473S6 L-Tyrosine-3,5-13C2 99.43% 否
HY-N0537S3 Xylose-2-13C 99.89% 否
HY-N0538S1 Xylitol-2-13C / 否
HY-N0545S Taurocholic acid-13C2,15N sodium Agonist / 否
HY-N0602R Ginsenoside Rg2 (Standard) Inhibitor / 否
HY-N0666S7 L-Aspartic acid-1,4-13C2,15N / 否
HY-N0733S1 Glucosamine-2-13C hydrochloride / 否
HY-N10579 Chrexanthomycin C Modulator / 否
HY-N10595 Ladanetin-6-O-β-(6′′-O-acetyl)glucoside / 否
HY-N10642 Pedaliin 6''-acetate / 否
HY-N10869 Pseudolaric acid C2-O-β-D-glucoside / 否
HY-N1150S4 Thymidine-13C-2 / 否
HY-N1150S5 Thymidine-2′-13C / 否
HY-N12447 C-2′-Decoumaroylaloeresin G / 否
HY-N1420AS2 Rhamnose-13C-2 monohydrate / 否
HY-N1480S2 (-)-Fucose-13C-2 / 否
HY-N3205 Neochamaejasmin B / 否
HY-N3231 Murraol Inhibitor / 否
HY-N3671 Cycloshizukaol A / 否
HY-N3686S2 D-Arabitol-13C-2 / 否
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.94% 否
HY-N6625S Chlorothalonil-13C2 Inhibitor / 否
HY-N6910 Pseudolaric Acid C2 99.17% 否
HY-N7092S3 D-Fructose-13C2 ≥98.0% 否
HY-N7398S 2-Pentylfuran-13C2 / 否
HY-P10655 Caloxin 1C2 Inhibitor / 否
HY-R00539 hsa-miR-30c-2-3p mimic / 否
HY-R00539A hsa-miR-30c-2-3p agomir / 否
HY-RI00539 hsa-miR-30c-2-3p inhibitor / 否
HY-RI00539A hsa-miR-30c-2-3p antagomir / 否
HY-RS00535 AKR1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01199 ATP2C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01227 ATP6V1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01738 C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01740 C2CD3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01741 C2CD5 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01742 C2orf69 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05907 GTF3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05968 H3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05975 H4C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09537 NR2C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09538 NR2C2AP Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09547 NR3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09548 Nr3c2 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09549 Nr3c2 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09609 NT5C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10511 PIK3C2A Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10512 Pik3c2a Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10513 Pik3c2a Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10514 PIK3C2B Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10515 Pik3c2b Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10516 Pik3c2b Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10517 PIK3C2G Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10518 Pik3c2g Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10519 Pik3c2g Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS14017 SULT1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W005355S9 Sodium 2-oxobutanoate-13C4 / 否
HY-W006057AS Sodium 3-methyl-2-oxobutanoate-13C2,d1 / 否
HY-W006057AS17 Sodium 3-Methyl-2-oxobutanoic acid-13C2 / 否
HY-W006057AS3 Sodium 3-methyl-2-oxobutanoate-13C2,d4 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W007928S1 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C-1 / 否
HY-W008507S (R)-2,3-Dihydroxypropanal-3-13C / 否
HY-W008807S Phosphoenolpyruvic acid potassium-13C2 / 否
HY-W010042S2 L-Glucose-13C-2 / 否
HY-W010452S2 3-Hydroxybutyric acid-13C2 sodium / 否
HY-W011683S1 2'-Deoxyadenosine monohydrate-2′-13C / 否
HY-W012684S Ethane-1,2-diamine dihydrochloride-13C2 / 否
HY-W012864S1 (2S,3R)-2,3,4-Trihydroxybutanal-13C-1 / 否
HY-W012864S2 (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 99.4% 否
HY-W013061S5 Propane-1,2,3-triyl tripalmitate-13C2 / 否
HY-W013495S Porphobilinogen-13C2 / 否
HY-W013636S4 2-Ketoglutaric acid-13C2 Inhibitor / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W015410S Disodium succinate-13C2 / 否
HY-W015883AS Fumaric acid2,3-13C2 disodium / 否
HY-W015883S2 Fumaric acid-13C2,d2 / 否
HY-W015913S4 2-Oxopropanoate-13c2 sodium / 否
HY-W016009S3 2'-Deoxyadenosine-5'-monophosphate-13C10 dilithium / 否
HY-W017018S1 L-Ornithine-1,2-13C2 hydrochloride / 否
HY-W017072S 1-Dodecene-1,2-13C2 / 否
HY-W017522S6 Adipic acid-13C2 / 否
HY-W018772S16 D-Ribose-1,2-13C2 / 否
HY-W018772S3 D-Ribose-13C-2 / 否
HY-W019796 Cbz-NH-PEG4-C2-acid / 否
HY-W035903S Ethanolamine-13C2 hydrochloride / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W040240S2 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 / 否
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / 否
HY-W048482S rU Phosphoramidite-13C2,d1 / 否
HY-W096111A Trt-PEG4-C2-acid hydrate / 否
HY-W096132 Dimethylamino-PEG2-C2-NH2 / 否
HY-W099580S Hexadecane-1,2-13C2 / 否
HY-W100312S o-Toluidine-13C6 hydrochloride / 否
HY-W338294S1 2'-Deoxycytidine-13C-2 monohydrate / 否
HY-W584529 VH032-C2-NH-Boc / 否
HY-W584532 VH032-O-C2-NH-Boc / 否
HY-W588192S 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 / 否
HY-W590667 C2 Ceramide-1-phosphate / 否
HY-W590670 C20-Dihydroceramide / 否
HY-W766769 Cyproterone Acetate-13C2,d3 Antagonist / 否
HY-W778203 Glycolic acid-13C2 / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) / 否
HY-Y0219S 1,2,4-Triazole-13C2,15N3 / 否
HY-Y0262BS Oxalic Acid-13C2 disodium / 否
HY-Y0338S1 Ethylene glycol-13C2 / 否
HY-Y0383S2 Dimethyl terephthalate-13C2-1 / 否
HY-Y0418S2 Dulcite-13C-2 / 否
HY-Y0677S Carbethoxymethyldiethyl phosphonate-C13 / 否
HY-Y0781S3 Pyruvic acid-13C-2 sodium / 否
HY-Y0966S11 Glycine-13C2,15N,d2 / 否
HY-Y0989S2 Acetophenone-1,2-13C2 / 否
HY-Y1088S Hydrocinnamic acid-2,3-13C2 / 否
HY-Y1206S Chloroacetyl chloride-13C2 / 否
HY-Y1250S5 Fmoc-Gly-OH-13C2 / 否
HY-Y1250S6 Fmoc-Gly-OH-13C2,15N Inhibitor / 否
HY-100043S 2-Ethyl-3,5-dimethylpyrazine-13C2 / 否
HY-114293S Acetyl coenzyme A-13C2 lithium Inhibitor / 否
HY-116700 Hinnuliquinone Inhibitor / 否
HY-118560S Tricyclodecenyl acetate-13C2 / 否
HY-119799 UK-500001 Inhibitor / 否
HY-121656 AKR1C2/3-IN-2 / 否
HY-125026 MyomiRs-IN-1 / 否
HY-125571 A 74704 Inhibitor / 否
HY-126830 Antifolate C2 / 否
HY-129252 Prothracarcin Inhibitor / 否
HY-130155 AMPK activator C2 Activator / 否
HY-132212 LH1307 Inhibitor / 否
HY-132223 LH1306 Inhibitor / 否
HY-132644S1 3-Demethyl Thiocolchicine--13C2,d6 / 否
HY-135928 Biotin-C2-S-S-pyridine / 否
HY-140157 N-Me-N-bis(PEG4-C2-Boc) / 否
HY-14164S1 Zileuton-13C2,15N Inhibitor / 否
HY-144348S N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N / 否
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride 98.01% 否
HY-150006 Pomalidomide-C2-acid / 否
HY-15121S1 L-Theanine-13C2,15N2 / 否
HY-156326S (3E,5E)-Octadien-2-one-13C2 / 否
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / 否
HY-158343 Thalidomide-NH-PEG2-C2-CH2 / 否
HY-160069 Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH / 否
HY-160235 Pomalidomide-C2-amide-C5-azide / 否
HY-161773 HL389-NHC2-PEG3-C2NH / 否
HY-164043 (S,R,S)-AHPC(Me)-amido-C2-acid / 否
HY-164391 Pomalidomide-C2-amide-C4-Br / 否
HY-165064 C2 L-Erythro ceramide (d18:1/2:0) / 否
HY-165072 C2 3'-Sulfo galactosylceramide (d18:1/2:0) / 否
HY-166226 C2 Sphingomyelin (d18:1/2:0) / 否
HY-167710 CRCD2 / 否
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / 否
HY-76204S1 Glycine ethyl ester-13C2 hydrochloride / 否
HY-B0031S5 Quetiapine-d4-1 fumarate / 否
HY-B0084S3 Dienogest-13C2,15N Agonist / 否
HY-B0124S1 Zonisamide-13C2,15N / 否
HY-B1290S3 2-Phenylethanol-13C2 Inhibitor / 否
HY-N0091S4 Hypoxanthine-13C2,15N-1 / 否
HY-N12156 Ajugasterone C 2-acetate / 否
HY-N12297 Ciwujianoside C2 / 否
HY-N7125S Cinnamyl acetate-13C2 / 否
HY-N7521 Procyanidin C2 / 否
HY-N9484S Menthofuran-13C2 / 否
HY-W001942S2 DL-2-Methylbutyric acid-13C2 / 否
HY-W010392S1 Ethyl 2-methylbutanoate-13C2 / 否
HY-W010489S1 2-Phenylacetaldehyde-13C2 / 否
HY-W012578S1 2-Isopropyl-3-methoxypyrazine-13C3 / 否
HY-W012932S 2,4-Dimethylthiazole-13C3 / 否
HY-W012980S4 Isovaleric acid-13C2 / 否
HY-W012998S1 2,3-Pentanedione-13C2 / 否
HY-W015307S 4-Ethyloctanoic acid-13C2 / 否
HY-W015604S 2,3-Diethyl-5-methylpyrazine-13C2 / 否
HY-W017049S Trifluoroacetic acid-13C2 sodium / 否
HY-W020678S 2-Methylbutanal-13C2 / 否
HY-W102356S1 Phenethyl acetate-13C2 / 否
HY-W127515S trans-2,cis-6-Nonadienal-13C2 / 否
HY-W343292S 2-Methylbutyl acetate-13C2 / 否
HY-W414466 C20-Dihydrosphingosine / 否
HY-W590664 C2 Dihydroceramide / 否
HY-W654105 C18-Ceramide-13C2,d2 / 否
HY-W654190 Fipronil sulfone-13C2,15N2 / 否
HY-W654241 Isopentenyl pyrophosphate-13C2 / 否
HY-W749251 5-Aminolevulinic acid-13C2,15N hydrochloride / 否
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / 否
HY-W778064 L-threo-Droxidopa-13C2,15N / 否
HY-W778154 O,O-Dimethyl dithiophosphate-13C2 ammonium Inhibitor / 否
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / 否
HY-W779002 alpha-D-glucose-13C2-1 / 否
HY-W923646 C24:1-Dihydro-ceramide / 否
HY-Y0045S 2-Acetylthiazole-13C2 / 否
HY-111555 AmPEG6C2-Aur0131 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Felis catus C2 VGNC VGNC:102387
Bos taurus C2 VGNC VGNC:53959
Mus musculus C2 MGD MGI:88226
Canis familiaris C2 VGNC VGNC:103663
Rattus norvegicus C2 RGD RGD:2231
Macaca fascicularis C2 NCBI NCBI:102137096
Macaca mulatta C2 NCBI NCBI:106997899
Others C2 NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z